ONCY ▲ +5.0% - Oncolytics Biotech Inc. $ONCY - Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer Oncolytics Biotech rose 5.0% today following the company's announcement of positive preclinical results showing that its candidate Pelareorep, when combined with a pan-RAS inhibitor, demonstrated effectiveness against colorectal cancer. The favorable early-stage data suggests a potential new therapeutic approach and may have encouraged investors about the program's prospects. 10-SEP-2026 08:15 AM ET